A groundbreaking study reveals that the intestinal nervous system, often described as a “gut brain,” actively governs the intestinal barrier, and when this barrier is compromised, allergy risks rise. International researchers emphasize that this gut brain is essential not only for digestion but also for preserving barrier integrity. A key player in this system is the vasoactive intestinal peptide (VIP), a signaling molecule that directs how stem cells develop within the intestinal wall.
In the absence of VIP, tuft cells can overproliferate, triggering reactions similar to those caused by allergens. Tuft cells reside in the lining of the intestines and continually monitor the organ’s environment.
Published in Nature Immunology, the study underscores the intestinal nervous system’s critical role in immune regulation and hints at new therapeutic avenues for allergies and chronic gut diseases influenced by diet.
Intestinal nervous system: A central health hub
Researchers from Charité – Universitätsmedizin Berlin and the University of Bern describe the intestinal nervous system as an integrated network of the mucosa, immune cells, and the gut microbiome, all working together to shield the gut from its own contents and to defend against pathogens.
The research, described as a first, shows that intestinal nerve cells communicate directly with intestinal stem cells via VIP, ensuring these stem cells do not overgrow into tuft cells.
“Our findings position the intestinal nervous system as a decisive factor in maintaining a healthy mucosa, modulating immune responses, and upholding an intact intestinal barrier,” says Dr. Manuel Jakob, the study’s first author from the Department of Visceral Surgery and Medicine at Inselspital, a research associate at the University of Bern’s Department for BioMedical Research, and a scientist at Charité.
He adds, “The gut brain is far more than a digestion aid—it serves as a central hub for overall health, immunity, and possibly conditions affecting large populations. Interestingly, the results imply that diet—specifically how food is formulated—could shape this effect.”
The findings, available at (http://dx.doi.org/10.1038/s41590-025-02325-1), reinforce the importance of a balanced gut microbiome and a well-regulated immune response in disease prevention.
Looking ahead, the team aims to explore how nutrition might be leveraged to support the nerve-gut axis and promote intestinal health.
“The mechanism we’ve uncovered could help explain why certain individuals exhibit heightened gut sensitivity and how we might tailor future interventions with greater precision,” explains senior author Professor Christoph Klose, head of Charité’s Neuroimmune Interaction research group within the Institute of Microbiology, Infectious Diseases and Immunology.
He continues, “By deepening our understanding of the interactions among nerves, cells, and immune responses in the gut, we can develop more targeted and personalized therapies—for instance, for allergies, irritable bowel syndrome, or chronic inflammatory bowel diseases.”
Related headlines
In other allergy, gut health, and immunity news, researchers note a troubling gut microbiome trend in US infants linked to increased allergy risks, with many babies lacking Bifidobacteria.
Additionally, AB-Biotics and Kaneka Probiotics introduced the i3.1 probiotic blend to help restore compromised intestinal barrier function in patients with irritable bowel syndrome after laboratory testing.
All content and features on this website are protected by copyright. Details are available in the privacy statement.
